HOUSE_OVERSIGHT_024837.jpg
1.41 MB
Extraction Summary
1
People
4
Organizations
3
Locations
1
Events
1
Relationships
3
Quotes
Document Information
Type:
Financial research report / investment analysis
File Size:
1.41 MB
Summary
This document is page 21 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing a strategic partnership between Cronos Group and Ginkgo Bioworks valued at $122MM. The text details the financial structure of the deal, including R&D funding and equity milestones for producing specific cannabinoids like THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, likely included in a larger cache of internal financial documents.
People (1)
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address michael.cella@cowen.com appears in the sidebar watermark as the intended recipient of the report.
|
Organizations (4)
| Name | Type | Context |
|---|---|---|
| Cowen and Company |
Investment firm producing the report.
|
|
| Cronos Group |
Canadian cannabis company analyzed in the report.
|
|
| Ginkgo Bioworks |
Boston-based synthetic biology company in partnership with Cronos.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024837'.
|
Timeline (1 events)
2018-09-01
Cronos and Ginkgo announced an agreement to produce cultured cannabinoids.
N/A
Relationships (1)
Report details a $122MM partnership agreement to produce cultured cannabinoids.
Key Quotes (3)
"The total agreement is valued at $122MM; this includes $22MM to fund R&D, and up to $100MM of CRON common shares"Source
HOUSE_OVERSIGHT_024837.jpg
Quote #1
"Using synthetic DNA to modify yeast and other organisms, the company endeavors to produce large amounts of various rare strains"Source
HOUSE_OVERSIGHT_024837.jpg
Quote #2
"we believe that this strategic partnership was integral in informing the entry of the largest tobacco player in the U.S., into the legal global cannabis market."Source
HOUSE_OVERSIGHT_024837.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document